![Anthony Zook](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Zook
Chief Executive Officer at
NEOGENOMICS, INC.
Net worth: 2 M $ as of 2026-06-29
Profile
Anthony P.
Zook is currently Chief Executive Officer & Director at NeoGenomics, Inc. starting in 2025, Chairman at Algorithm Sciences, Inc. since 2021, Executive Chairman at Voltron Therapeutics, Inc. since 2021, Independent Director at Adaptin Bio, Inc. starting in 2025, Trustee at Healthcare Leadership Council, and holds a position at Laidlaw Venture Partners since 2021.
Former roles include Interim Chief Executive Officer at MedImmune LLC, Chief Executive Officer & Director at VIVUS, Inc. in 2013, President & Chief Executive Officer at AstraZeneca Pharmaceuticals LP and Astra USA, Inc., Chief Executive Officer at Innocoll AG, Chief Executive Officer & Member-Supervisory Board at Innocoll Biotherapeutics Holdings Ltd. from 2017 to 2019, Chief Executive Officer at Innocoll Biotherapeutics from 2014 to 2015, Independent Director at Streamex Corp.
from 2020 to 2022, Director at Frostburg State University, Melinta Subsidiary Corp., American Cancer Society, Inc. Pennsylvania Division, Pharmaceutical Research & Manufacturers of America, National Pharmaceutical Council, First State Innovation, Inc., Inhibikase Therapeutics, Inc., AltheRx, Inc., ViralClear Pharmaceuticals, Inc., Executive Vice President-Global Commercial at AstraZeneca PLC from 2010 to 2013, President at MedImmune Ventures, Inc., and Partner at Lucius Partners LLC.
Education includes undergraduate studies at Frostburg State University and The Pennsylvania State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEOGENOMICS, INC. 0.12% | 2026-03-31 | 152,011 ( 0.12% ) | 2 M $ | 2026-06-29 |
Anthony Zook active positions
| Companies | Position | Start |
|---|---|---|
| NEOGENOMICS, INC. | Chief Executive Officer | 2025-03-31 |
Algorithm Sciences, Inc.
 Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company specializing in pulmonary arterial hypertension | Chairman | - |
Voltron Therapeutics, Inc.
 Voltron Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and discovery of vaccine and immunotherapy center | Chairman | 2021-01-27 |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Director/Board Member | 2011-01-03 |
Former positions of Anthony Zook
| Companies | Position | End |
|---|---|---|
| STREAMEX CORP. | Director/Board Member | 2022-04-21 |
| INNOCOLL HOLDINGS PLC | Chief Executive Officer | 2019-02-28 |
| VIVUS, INC. | Chief Executive Officer | 2013-09-02 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2013-01-30 |
Training of Anthony Zook
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
23
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures invests in private biotechnology companies located across the globe primarily in North America. The firm focuses on healthcare sectors such as molecules, vaccines, pharmaceutical technologies, medical devices, diagnostics, imaging and healthcare IT. The firm provides financing for seed, early, later and mezzanine stage capital requirements with an investment size ranging from USD 5 - USD 10 million per round. It acts as a lead investor and takes an active role on the board of directors. | Finance |
BioSig Technologies, Inc.
 BioSig Technologies, Inc. Investment Banks/BrokersFinance Operates as an asset tokenization company that provides blockchain technology to tokenize gold and commodities | Finance |
Frostburg State University
 Frostburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Healthcare Leadership Council
Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
First State Innovation, Inc.
 First State Innovation, Inc. Financial ConglomeratesFinance Provides investment services to technology-based and early stage businesses | Finance |
Astra USA, Inc. | |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Altherx, Inc.
 Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Commercial Services |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Algorithm Sciences, Inc.
Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company specializing in pulmonary arterial hypertension | Health Technology |
Voltron Therapeutics, Inc.
Voltron Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and discovery of vaccine and immunotherapy center | Health Technology |
Viralclear Pharmaceuticals, Inc.
 Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to fight SARS-CoV-2 virus that causes COVID-19 | Health Technology |
- Stock Market
- Insiders
- Anthony Zook
Choose MarketScreener 
